This is the list of companies and organisations who
will be attending the 7th Annual North America Forum for Investing & Partnering
in Biotech, Boston 2008.
| 4-Antibody GmbH |
| 4s3 Bioscience, Inc |
| Abingworth |
| Advent International |
| Aisling Capital |
| Alnylam Pharmaceuticals, Inc. |
| Alpharma Inc |
| Alseres Pharmaceuticals |
| Altius Strategy Group |
| Anglo Irish Bank |
| Apeiron Partners |
| APS International |
| AstraZeneca Pharmaceuticals |
| Atlas Venture |
| Attogen Biomedical Research |
| BankInvest Biomedical Venture |
| Beth Israel Deaconess Medical Center |
| Bio IB |
| Biogen Idec Inc. |
| BioHealth Management |
| BioMedInvest AG |
| Biophan Technologies, Inc. |
| BiotechPartnering Solutions |
| BioWa, Inc. |
| Borealis Ventures |
| Boston Communications |
| Boston Consulting Company |
| Boston Globe |
| Bristol-Myers Squibb |
| Brown Brothers Harriman & Company |
| Cambria Biosciences |
| Cambridge BioPartners |
| Capital Royalty |
| CBT Advisors |
| CDIB Bioscience Venture Management |
| CellTraffix Inc. |
| Cequent Pharmaceuticals, Inc. |
| Channing Laboratory, Brigham & Women's Hospital |
| CMT, Inc. |
| Coley Pharmaceutical Group Inc. |
| CommerceNet |
| Conforma Therapeutics Corporation |
| Cyberkinetics Neurotechnology Systems, Inc. |
| De Facto Communications |
| Deutsche Bank AG |
| DFCI/HMS/BIDMC |
| Differential Proteomics, Inc. |
| Domain Associates LLC |
| Edwards Angell Palmer & Dodge LLP |
| EGS Healthcare |
| Endpoint Research |
| EntreMed, Inc. |
| Epigen Consulting |
| Ernst & Young |
| Exelixis, Inc. |
| Fidelity Biosciences |
| Flagship Ventures |
| Forge Partners |
| f-star |
| Gai & Patner |
| Genfit |
| Genomic Healthcare Strategies |
| Genzyme Corporation |
| Georgetown Medical School |
| GGA Software |
| GlaxoSmithKline |
| Goldman Sachs International |
| Green Hills Biotechnology GmbH |
| GSAS Harvard Biotechnology Club |
| HALLORAN CONSULTING GROUP INC |
| Harvard Clinical Research Institute |
| Harvard Medical School |
| Harvard School of Public Health |
| Harvard University, Office of Technology Development |
| Harvard-MIT Division of Health Sciences & Technology |
| Helix Management Inc. |
| Henry M. Jackson Foundation |
| Hercules Technology Growth Capital |
| Hoffer Associates |
| Hub Management Investment Group |
| i2Chem |
| Immune Disease Institute |
| Immunovaccine Technologies Inc |
| Intertech Strategies |
| Invest Quebec |
| Katan Associates |
| Kenta Biotech |
| Lexicon Pharmaceuticals, Inc. |
| Life Science Insights |
| Lipoxen plc. |
| Louisiana Fund I, L.P. |
| MacroGenics, Inc. |
| MDJ Consulting |
| Medarex, Inc. |
| Merck & Co |
| Mercury Therapeutics, Inc. |
| Merrill Lynch |
| MetaHorizons Translational |
| MicroCHIPS, Inc |
| Mizuho Corp. Bank, Ltd. |
| MP Healthcare Venture Management, Inc. |
| MPM Capital LP |
| Musket Research Associates |
| Navigator Technology Ventures |
| Neomed Management |
| Nerites Corporation |
| NeuroHealing |
| New York Academy of Sciences |
| NGN Capital LLC |
| Nicolino Associates, Inc |
| Noble Fund Managers |
| Novartis Option Fund |
| Novartis Pharma AG |
| Novartis Pharmaceuticals |
| Novartis Venture Funds |
| Novo A/S |
| OctoPlus N.V. |
| Oppenheimer & Company |
| Ormed Capital LLC |
| Oxford Bioscience Partners |
| Oxford Finance Corporation |
| Paramount Bio LLP |
| Paratek Pharmaceuticals, Inc. |
| Peptech Limited - renamed Arana Therapeutics Ltd. |
| Pfizer Canada Inc |
| Pfizer Inc. |
| Phenomenome Discoveries Inc |
| Photo Dynamic Therapy LLC |
| PricewaterhouseCoopers LLC |
| Prism Venture Partners |
| Procter & Gamble Pharmaceuticals |
| pSivida |
| QUATRx Pharmaceuticals |
| Radcliffe Consulting, Inc |
| Radius Health, Inc. |
| RCT BioVentures |
| Ricerca Biosciences, LLC |
| Rockport Venture Partners |
| Santaris Pharma A/S |
| Sapphire Therapeutics |
| Scientia Advisors, LLC |
| Scientific Legacies |
| Scimitar Equity Research |
| Semaphore |
| Sherris Pharma Partners |
| SMC |
| SR One |
| Summer Street Capital Partners |
| SV Life Science Advisors |
| Sycamore Ventures |
| Syntaxin Ltd |
| T2Cure GmbH |
| The Communications Strategy Group Inc. |
| The David H. Koch Institute for Integrative Cancer Research at MIT |
| The Mergermarket Group |
| The Pentad Group |
| The Pfizer Incubator |
| Thermo Fisher Scientific Inc. |
| Tiburon Bio Consulting GmbH |
| Translational Therapeutics |
| Tufts University |
| TVM Capital |
| University at Albany, SUNY |
| Ventaira Pharmaceuticals |
| Venture Investment Management Company (VIMAC) |
| Vivo Group |
| Vivo Ventures |
| Warren Pharmaceuticals Inc. |
| Wellington Management Company |
| Wilex AG |
| Yasuda Enterprise Development Co., Ltd |
| Yorkville Advisors, LLC |